Switzerland - Export of Extracts of Glands for Therapeutic Use
Since 2014, Switzerland Export of Extracts of Glands for Therapeutic Use decreased by 22.2% year on year. With $2,523,329.75 in 2019, the country was ranked number 17 comparing other countries in Export of Extracts of Glands for Therapeutic Use. Switzerland is overtaken by Argentina, which was ranked number 16 at $3,422,711.48 and is followed by France at $2,495,229.39. United Kingdom topped the ranking with $131,260,542.7 in 2019, that is an increase of 178.2% compared to 2018. United States, Denmark and Japan respectively ranked number 2, 3 and 4 in this ranking. Oman witnessed the best average annual growth at +213.6% per year, while Kazakhstan witnessed the worst performance at -68.4% per year.
Date | US Dollars |
---|---|
2019 | 2,523,329.75 |
2018 | 3,313,587.50 |
2017 | 3,333,585.75 |
2016 | 8,051,727.00 |
2015 | 7,969,429.00 |
How does Switzerland rank in Export of Extracts of Glands for Therapeutic Use?
# | 83 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
United Kingdom
|
131,260,542.70 | 2019 | +178.2 % | +53.0 % | View data | |
2 |
#2
United States
|
53,333,163.81 | 2019 | +1.2 % | -3.8 % | View data | |
16 |
#16
Argentina
|
3,422,711.48 | 2019 | -2.4 % | -3.1 % | View data | |
17 |
#17
Switzerland
|
2,523,329.75 | 2019 | -23.9 % | -22.2 % | View data | |
18 |
#18
France
|
2,495,229.39 | 2019 | -3.1 % | +3.0 % | View data |